Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers	Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Stomatognathic Diseases, adenocarcinoma, adenoid cystic carcinoma, carcinoma, epithelial neoplasm, mouth disorder, neoplasm, salivary gland cancer, salivary gland disorder	Active, not recruiting	Phase 2	2026-10-09		NCT04209660

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Eisai Inc.	40
Memorial Sloan Kettering Cancer Center	753
Merck Sharp & Dohme LLC	650

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Baptist Alliance MCI	Miami	United States	6
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)	Basking Ridge	United States	56
Memorial Sloan Kettering Bergen (All Protocol Activities)	Montvale	United States	82
Memorial Sloan Kettering Cancer Center (All Protocol Activities)	New York	United States	230
Memorial Sloan Kettering Commack (All Protocol Activities)	Commack	United States	20
Memorial Sloan Kettering Monmouth (All Protocol Activities)	Middletown	United States	92
Memorial Sloan Kettering Nassau (All Protocol Activities)	Uniondale	United States	53
Memorial Sloan Kettering Westchester (All Protocol Activities)	Harrison	United States	86